A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.
A sub-national real-time epidemiological and vaccination database for the COVID-19 pandemic in Canada.
复制标题
DOI：
10.1038/s41597-021-00955-2
复制
发表时间：
2021-07-15
期刊：
影响因子：
9.8
通讯作者：
Soucy JR
中科院分区：
文献类型：
--
作者：
Berry I;O'Neill M;Sturrock SL;Wright JE;Acharya K;Brankston G;Harish V;Kornas K;Maani N;Naganathan T;Obress L;Rossi T;Simmons AE;Van Camp M;Xie X;Tuite AR;Greer AL;Fisman DN;Soucy JR
2019冠状病毒病大流行表明，需要实时、开放的流行病学信息，为公共卫生决策和疫情控制工作提供信息。在加拿大，提供医疗服务的权力主要在省和地区层面;然而，在疫情开始时，没有明确的泛加拿大COVID-19数据集。COVID-19加拿大开放数据工作组的成立就是为了填补这一关键的数据缺口。作为一个志愿者贡献者团队，我们每天从各种政府和非政府来源收集COVID-19数据，并整理加拿大所有省份和地区的病例和死亡率列表，包括有关地点、年龄、性别、旅行史和暴露的信息（如有）。我们亦整理COVID-19康复、检测及接种及分发疫苗剂量的时间序列。数据以精细的次国家规模进行系统记录，可用于支持对COVID-19热点的深入了解。我们将继续维护该数据集以及随附的在线仪表板，为研究人员、记者和公众提供可靠的泛加拿大COVID-19资源。描述报告数据的机器可访问元数据文件：10.6084/m9.figshare.14331311
The COVID-19 pandemic has demonstrated the need for real-time, open-access epidemiological information to inform public health decision-making and outbreak control efforts. In Canada, authority for healthcare delivery primarily lies at the provincial and territorial level; however, at the outset of the pandemic no definitive pan-Canadian COVID-19 datasets were available. The COVID-19 Canada Open Data Working Group was created to fill this crucial data gap. As a team of volunteer contributors, we collect daily COVID-19 data from a variety of governmental and non-governmental sources and curate a line-list of cases and mortality for all provinces and territories of Canada, including information on location, age, sex, travel history, and exposure, where available. We also curate time series of COVID-19 recoveries, testing, and vaccine doses administered and distributed. Data are recorded systematically at a fine sub-national scale, which can be used to support robust understanding of COVID-19 hotspots. We continue to maintain this dataset, and an accompanying online dashboard, to provide a reliable pan-Canadian COVID-19 resource to researchers, journalists, and the general public. Machine-accessible metadata file describing the reported data: 10.6084/m9.figshare.14331311
登录
查看更多内容
BNT162B2 mRNA COVID-19疫苗的安全性和功效。
DOI：
10.1056/nejmoa2034577
发表时间：
2020-12-31
期刊：
The New England journal of medicine
影响因子：
--
作者：
Polack FP;Thomas SJ;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Moreira ED;Zerbini C;Bailey R;Swanson KA;Roychoudhury S;Koury K;Li P;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Jansen KU;Gruber WC;C4591001 Clinical Trial Group
通讯作者：
C4591001 Clinical Trial Group
影响因子：
168.9
作者：
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者：
Cao, Bin
影响因子：
15.8
作者：
Modjarrad, Kayvon;Moorthy, Vasee S.;Kieny, Marie-Paule
通讯作者：
Kieny, Marie-Paule
DOI：
10.1098/rstb.2016.0371
发表时间：
2017-05-26
影响因子：
6.3
作者：
Cori, Anne;Donnelly, Christl A.;Blake, Isobel M.
通讯作者：
Blake, Isobel M.
影响因子：
9.8
作者：
Kucharski AJ;Funk S;Eggo RM
通讯作者：
Eggo RM